High Tide begins selling cannabis seeds in the United States
Goldman Sachs analyst…
Goldman Sachs analyst Chris Shibutani upgraded Pfizer to Buy from Neutral with a price target of $60, up from $47. Positive updates from the company’s pipeline, and the potent…